Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0001
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2010 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. John B. Stuppin | Founder & Director | 28.12k | 3.9k | 1934 |
Neurobiological Technologies, Inc.
2000 Powell Street
Suite 800
EmeryVille, CA 94608
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Corporate Governance
Neurobiological Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
December 27, 2012 at 12:00 AM UTC
Dividend Date